Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Clinical Trials
The MUSTT Trial
Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.
December 16, 1999
Clinical Trials
The MADIT Trial
In patients with a prior MI who are at high risk for VT, prophylactic therapy with an implanted defibrillator leads to improved survival as compared…
December 26, 1996
Clinical Guidelines
1996 AHA/NASPE Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations
The American Heart Association and the North American Society of Pacing and Electrophysiology (NASPE) cosponsored two conferences on medical and regulatory issues related to arrhythmias…
September 1, 1996
Clinical Trials
The CAST Trial
Antiarrhythmic drugs flecainide and encainide may actually increase mortality in post-MI patients with asymptomatic ventricular arrhythmias.
March 21, 1991
- « Previous
- 1
- …
- 59
- 60
- 61